{"id":913486,"date":"2025-11-25T07:40:32","date_gmt":"2025-11-25T12:40:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/"},"modified":"2025-11-25T07:40:32","modified_gmt":"2025-11-25T12:40:32","slug":"bridgebio-to-participate-in-december-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/","title":{"rendered":"BridgeBio to Participate in December Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PALO ALTO, Calif., Nov.  25, 2025  (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:left\">\n          <strong>Piper Sandler Healthcare Conference, New York, NY: <\/strong>Fireside Chat on Tuesday, December 2 at 10:30 am EST<\/li>\n<li style=\"text-align:left\">\n          <strong>EvercoreISI HealthCONx Conference, Miami, FL: <\/strong>Fireside Chat on Wednesday, December 3 at 3:00 pm EST<\/li>\n<\/ul>\n<p>To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents and Presentations\u201d page within the Investors section of the BridgeBio website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8BnPsaGT8SyEEdVs-nm9HCLovOHqGpOEqlLo3jLugnNB-CqKN-H13-P3hIIBONX79CctodTUpmZBvGyJ5jMe9_8yQBGa3aU2siOZs14AL-HTzuFnj4WhCEjo5XoL3cxu\" rel=\"nofollow\" target=\"_blank\"><strong><u>https:\/\/investor.bridgebio.com<\/u><\/strong><\/a>. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.<\/p>\n<p>\n        <strong>About BridgeBio Pharma, Inc.<\/strong><br \/>\n        <br \/>BridgeBio Pharma, Inc. (BridgeBio; Nasdaq: BBIO) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio\u2019s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TNG3bBjc7UXPOH0NotS8SHvlisEm2iubudT9AYv_yJgLedxvRyqxYhk6nQomI3MMPbyXymNJBh_XAFm71VOBiY_lZrlnZ5VMvslT5ChvqEAnrf6ZNHHQgpFVdc0T9NLTXq3dk6LwOV1ysvPOWaHISpn3ni6XPmGQgHESrNY7auIHG_i8gfHudKIDsPUvMat923Uw5xp1wuXjHs35dsCHaylfO7Wo8LuzRXrIS3M6Dwok2gv2QUMwwETEzfeY4jXIVRB2m2wyXAR1i5ytJLwsSTgeTIUFYR_8StC1bVXValsbHPsICHYNEJCIWBtSGxbsAqWwOstZ27fuUVs2BbYVBnZIz5c6r0WunJxBofd02ik_NCQVJIF-AbMtxu9Z1MRx1QIq7BoWLEGVS-OMgCGgVw==\" rel=\"nofollow\" target=\"_blank\"><strong>bridgebio.com<\/strong><\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v7eFFAy0aUtA2IXf-D90uo9-W0pz3qvIY3cRsaXXEPHOMVUH4-aaqJOCQjkgmZLyD63gCWY_YwNibK4iBrrZgd2usroW4jquH1BlgaLx49xKtWSM4fMBXQ0W5CGO1JCweN3PIB6O5k3smned3YOsAtJzYc2tpZc0wdvcW4NMPIoKXWt5ME9ennXepM1n3sLV9lSZ3926_wlZvRvjASD7CW-rHJ6Y2Vandg5ZSXPnlHJdXjiWMyOZj4seTW8LtLFYETsV8_uEmHhO1NhghUbUQIlRjnLxk6OJT5RDRXQAOFTd4w7jvtpk0CkfbsDUuVKrBEPH6n2JvN8I_X3WuSOEnToD6oWHVNFA9VPGT6RlGlheJTdyOxuSX2LctG1r4urLNKf7_0mh2PajhdMQWMChpmyqJ_kgmggSMAkV7iTdtt0=\" rel=\"nofollow\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RSdBxR-bp9ov2eJJ_2CbzR6yh_6UyKZ_Xw-cNgzuroeAhUrBpashAWEhD2YHF5D96cIVgKqvPwnF5-9kCpntE2Ga9xVhnpZrA27QQlMhMcC6YTjmyVP7Gm2zCl98nsyoxSev5Qh_bGeggmAkr-hNvzF_RsHQgnTgvcxH-bOZIk60zM4pKS6r-qXfMnTLh0PGlN4Y2HUGhBGko0D8vUno5IGufuWojkbB6wb9zcH_plFQY7BiMpaeJVOCsgG20IYwkai1cpm3inqp_9AJO7oNshU28iTJ0eIgl1o7E1oakGWKVoZUiGs_w9W1Jc3Qhl_5LKw1McenA5mdZzqCmf638UEh-As3Ozk4MChluNSvsxmwm8kgbUENnpnGnqIi6RFNC7WUlU45ZnbXvnU2FDoeMA==\" rel=\"nofollow\" target=\"_blank\"><strong>X<\/strong><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a3SxhL437E6EgbOomLtIMkHhhXnZ9rLMwfioJV9E8fI3eqY2Z7Qv25AHJlEAm7-kZYC8ussnI56-70rEuwiOXtWxRuKc_Rx5RB2nbTr5MhmnuQFkbcpfUt15I0XpZJpSBes-6bLpcnBb4BkcPlTSWINLypN1xwc61Iu1OZMzpXkZ6o1Rj_Xe5AytxVGwR60Yt-sGj_nod3zFw-SPGmgwPZdDvVYE2dEbpDnVvaJuH9kfb_PKXaQXxWmSrElaLt-PzXhYdXeZvgAykhCqePSq5iW44V3QG_BVqjGCr7qGozwOvHjrtgqaCX_UMtOm1SIQmO2YFD7vWo9UbJyTRPCvXLT5QUzArd5Xe33bUPitiwcf4ONJWo8jmI16dO3Z38tCs7VLVjyo7_j9keLwh8LVbhaqI7hop7pwZ1j7L4F4F8HJoc0zbG02bfzamO0dxMW6skNJPJRmVMkzxM78KYhMtqEczLTifStlhKchH5bJ3IG7mjI2cHdakmmsk1G8wm5lz8zTofkTKe_CS4eNW3GiBc8GUxUW-499GWoPTPDPTn4bXvqVsDSWpmnkUrZ5TO2hgjQ50h-vu-CVhvWogAYVcwNduWG6IRaeUD-bTwiaA5oA5nFY3OdyKzvCR1S_Q_T8d-DgS9B77Bekrxf_rJSPge8c3bReWSuRXWkl4c9xZNHkoIHhuXt4pE98-Lr-IbIhPmI0xW1n-VKrqD4Z18NxGJQEQxXxQK5j42gAqflSgpid66C352mXtoMvqtgMi3Gzn7zQQlAFtOnGJc9RSV9mf5xbV-ULf2-vbGshSHCQlLxx8h1l5_HCxdtZTcI9A3_4dN7ecOqGchb4pbrbXgpMNm6e_yGPir7HZoSspOQgLmGvWBChIZl8Vn9mQsMelcqvN4CJgtRVahroAmJYzqWCtyMy9-mQCPNm0JZeK-pMST0Z2zYdSlw9Wgy1Pzk8ZRqlNHhb9QQMY6un385McnJVhfYx3rpD27O0Z7KCMDC2b4q0Kq5Fu8It8rwJIFdAULgsOwSmSsOOJOgcgA6UjmD2oxX79LyRCcM4BjNxex-NLNfbu79LhII3ysuf4prTcnjUPMqzALfjXDEDqufTxSC96YLKNHNaK6Vg8PdokHGcPMhLZKJfU2TqmPFoNw3_C7WXmNaCh3koDr5T_lDZOvPRkGYSGoMtTFh6ocWcpQ3xsxZSJ7e2YIlngJzoFH_YJN0ueo9rDVya0lt_liSekr6nJIbVtNUzj3CchITvgR3Gey9AJQ22VXMWYJUeaNdgNHGEP48yArNEX-bLBjaOptOYbKJZgYyRkdtuhdtsM7k2K2QubxRGx8tUbf_U79uqpUkiW8TukRi-QD4A4pfgY3dIdNJ0t5XQbvye5AovYJ5kPEnv3y9q1UpiLhsA8TS8PRzgUDJQnHpyEaJaCLbkYQaTVaGa5uW4fhH5SgvRS56-hHAp3jP6pNdoNoS9yNMSV35dZ_oc4njdHUaObG4Jg0x486UOR4e6r9Jng7UgXX64LRTQsn-xEalAk-XWjkCwusCYJK9wJXARwiF1enR8MNLVot4I2F36FIkf-UDEudIW1M1uY5cjxI8rm7WW3WM123UHysfqQtj2Wdbwyuy0N5sarSYK8NskoT2GYgC7M1Tce0Y9Ft8xiXsvNRW3yCZDDIYfBcbYd_31uzRBCrW4Wj0N98I4OuOa96rLPSXzh2v00dBcNPII875TjPG4V5S0gNllUu2oQJAw7wXoIGirr2sxdi4EppG3fi3oSjlXJcGd69jqYakCXsiqJexwjz0g6iNjhsQVShvJPJ0oHBvIRPO_hYiwr3PJI1avogXoFc0UpmFY-CKVW6k7cPvT21wf938gWS_XOG79rQg02ejgfLlSL6mZgbWjQEllXuPh1yfeNzrZqkqsQZS1eUdxJpPZ3H8rstA_BY_c3lVSKs5Y14UAAMXMKu1P_0fAmDe5dOfOVFvm1aBY7zYP4OmKnlrLCT-DPKIpCwqml4yRMhG6-J6gkok_eP0j2D89Pvq4w4ilkD3gE1vlI5E-0ttXLomO2g-Nv3ukxOuHX3_ZPNXXpbFZ8NT92jwi2OhG_dYUCtdlf4zJK_cxnhNe5dh-ByNl3rSppuEU1CUQ_2Ncb-aLhOiVfxl9679W1eEymadNeMFluzVMP6lBfvt9mtrmYjG7uB4GJow_9r80ItG6FDUtiFcbDLQ-_J1tPXZE4J55zA3lv7_pcw_RQ87xSkMt_PLjUdy7E_pDadvxqTGdnhmEeIKre7kBrG83f8Ry-HmZmyeuF8cJjkf3k5e2uD12OETBBjuQ0vhJ2iDP9lYL0Def7_WMI7XY2YXpgLyqTUVmhZjDWSio_7ubdoZk7Qj4_0iu5MJDufcTAOtmFrreROKXBHlqA4wAU8aHPCMdLkwjWHHrP9rpzXx-7HuCo0-H6JsSWBt4QOAvhN_VskTK08fv-CTK7Qu9eB-58q7kXcynf1cZbJLm1QgawbXgyBJpebY1jEpWKzYnOyOzb7RaDB_stJg4hW0NYlV6arJmS8TdW_j2QcFUBD-dFuYk5A-iRozJ61SQhyR3nVQ9dokjUJctywfObnlscH2YvtlZHEFUeYDCae9QLcbI6FyJ1SnVYLzE8yg7yVWgd4e7KmXtE4CykInpdUHF7B1H6Tk85luGLonMRB7yiXcSWPI6ItfV3VQD53W6zJy2piacw2pbAzxr9fVm00deJxT-m6D7pdP029m_WvBilPvsMVnpURZlAUwRn55yBKg7KBkK6mcztVVySLgcGhP6q5iIbyuYH8HMS-B8lUBOv8fBUHLiOl_sBLXwRrrNokdSkgUAVk7xDDFlnHQitv-hhiOMQrAYf0scPCqZVJha3CepyVMc6TwC5EIRZ2EiwSHGNxTaCEcZxrXPNTvw4AKH8rVFCyh-R1DKjE1znmrVAPt8tAtA7_jGeNhe3HiQkNsBXNP4BLcf9fAoo-nkxZtdDLqqMoqy3huDnYj-ysdwemOa27i7PgWsDUeCGsHxECgwhPPc5IA7xFfpcUxeWIx9nDJQ9AHEfO5GqDFM7xjMEVdOAWzRqnDGZ63zgTjjaos7dBpVSoaSP-eKvR4vTA8157cBuUhX3QEI7h0i-oesvQ7FXy3Tioa91W7Y_AEcqjnxckLcsf1rjb1RveAOHtKy1JxP6dWjPtM6hDrDNZmCLQyn-MtR2mKjfwa-4M5sYJMCUiKbqCc9rZBmgwAMq59WnVRjT6gkrohrL_x-bEz1DGoAASXS5QPeF8bRCHC-uCHD8T-Zpi8rnsD6wDR46zwr78WTZlWz7bxsjb4ejDy1Q4Csv6gh0_am-qGjLmKr9Asw8GXVYn89_mnypyTsccxbhcAUIL4AlUl5qiSXtZ3Fd7y7sc4azBEPiTdaPXGYBjTteTGJ5MnOZhfwJVi-vux7BGpXAwE36kwEVqRaKzQ79_aFjt70faLcbrRRwKqZo2Yy4kyE-pXNRD-VQUmOW3ru0cO77uP3T9dae6gGuKme8QueMeZX-jBoNExg5dO-wMR1RCD-JCzcpVSK0lOuseS58b6NzcMGnd3-PvSJtPSQgpfPc4iXldve0otlQ9JfhASuzm3EWj3S0Gyb6Lc4O3ThIsd9WA6H-cFrL6DDlcdMB_Or_Ra05FR1yl5Q9EoFI_q1pfH7kPNiqFeDV8LA4o9svwIU_yg-TwqsMYChzu5rn4LP_O_heO6KverI9ef4RHHJ4R9legUUqgq9AX_MMkty8a7qE6oqaUsz8phDa5UyTQfewuiRzGPqhNz0nF7wAsAGTHg_tYr3eUOrl2no04NHneDv5opsiI16lprjvp_1M_rREcBwB9EXSLGYlMUsG0b5muz7u0GLXvhPSOoyUVHCk-2S4fm4vKSztXnTMmKC_99QM3OwK8ityKEXfWIZ1D_m0N-yFpAVhmU7_dwmy0IK7v70z36n05BygyQqf2xiX7mfPU0N5oWawrsXM0DM\" rel=\"nofollow\" target=\"_blank\">, <\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KrXI0hcm6u1zoKJcbXHAR7i_0ZzW8xytZrwcWExUfUwgij6CZB3BhdyMdedT7mcl_XF2JlyJzYl9kGHyUlq9VYzbM21l3iqAk7t8oaXAVrWgV3hYB7PJo-mV0eNpJYNs8gBQRsyDo_0X_uOAuQ-BNCnyfOFv3KcU383A6Znl-ieHQ68hxN2RmCIKiazyhz-YHjKE5YEmiYf02oRp5BFcqOoENAdL00jVaou7gmgL2wLgYOpF1Eo5aN-bU9d4X9jwOO3yUQcdlIZS3waxJTkYI8Sxand77ALJ1FJ97YtZUNuWLoTYgUGseMmkr-Iq4QYib4RQzAAwq3W0KpIwxB7W39wWNR3vjlID5ntbNjHGYN3hi1gX8TmDpb5tLMvV5XloJH4HU-thnaBPmqfxRz2SQpR5kMKAHEzedk2Si3-LCFI=\" rel=\"nofollow\" target=\"_blank\"><strong>Facebook<\/strong><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=USHOwByW4ZWihU2lLHl54JQ8rfk4-_yqBk-hTFIFRs81vEFf3HwKUkhZ9u345H2d6Geky92PzkBi-YW_4QmiYr-xg5ySmvfUW0Kkbc4PUVjZvrqe-Ih3mtJ0DDAXfj6mkTcYN_pKNWeYhBSZLeuxoWWiIuKlnsmdSukM62fE-kdNiw01uGz3bvi1FFgvgKaK60lfd0dK2bUD5adwVdMbA6CjL2vjYQFmxQNgjnX2jvhIDsUnIWE4XWpSJaFMrRZ_-2P0KlwTxKXE22iPZAMsTSHYYXAhQZ8FyeDC4T7Q6rXd32qEFYfEr-zVmPU9yxmVIguEtn5snvuGXNerbslBccpfMHhcxidhpTI0GnfD462a3HZE3xM8OBiCm3WDOW6wiK1oUwuaNXmBnNt-dt2WK_p9P5tYg99fxiFE2FRLz7o=\" rel=\"nofollow\" target=\"_blank\"><strong>Instagram<\/strong><\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S11f8ggwLjrMgvYjdYINQ0DHbJ44PX9gWX70Bh285JvkffJBexJiPuLDVsYea2mRyI_6MwhgT2Yf4oLLLmkHVTNejJ6v84vtu_lDTnBK5354J9wJYmXvTcbnebeyTL3xVkaFNaQ594BCsLR_UYq93fQQRM0E5a3gNlB0y33rvbftOVChnF70maT9pj4tOVgmqyBP5dlWMAP7jAXUVj5fMOA80ne6g3UP07jvezeXl1UhFC0m_u8UGPmWWicEQXAx_VMwVTXLhLxxVtAWIjBCn1zxw2txR-NxkhK73hQmKotR9h_3tRGT8MxzN1xIkuyQy1eORgvLOl-x4iUuN5T4h3tVwgZPY3aeldwLPBzTogAweDEAw6mvfdwgMoSUo7VcfxdMHiw_lf_NXpdtOZRUjLfHZZV0qI6q2Rr3PxWDthw=\" rel=\"nofollow\" target=\"_blank\"><strong>YouTube<\/strong><\/a>.\u00a0<\/p>\n<p>\n        <strong>BridgeBio Media Contact:<\/strong><br \/>\n        <br \/>Bubba Murarka, Executive Vice President, Corporate Development<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dSzbDGRGEz0SvjgSVXVWdE79YBTgYRYZ83ddGONE19PN0vMUq3F1LiDRmDoabOrmqzIC9bm6WFYtT0XWWJRjBaPdeo0PdVuRVzPDudHPQ3_l5Jm7uwxgoC1ayVEGcJNUuGDx2lXU0rJYe6xp4uxrLLBzt7Hs4I1lcr0eK7o5USXkTUyP5V15V--qqpw_YaUQYc4CUP27kvk2Zx4SfGQp1jSAB1uqAY3LsPITz3elwLL3Tiu2wN-gjY6EBGrUkhYZ7_fKEVGGx6vBqsU3cYwipQqJLluX4GLGh8NpqxMvH0wGu1fd-HjXMtBwzSRF1PCLja6FNIdp2-ZxnYebYopvuSsXZGjtwONhYX2865FgQqKm2hdwhG7-xwEHy7GisuYTlvuIyHcWcSQpWiCaNgq5kFQ9RFffAwDhd-unBfHZss-I5Yln8mjGiMdWMBWdsFD4cEyR-0dcFYTEZkJRwo9EzAmbyhB7uFetYzYjRDjLxgUQ9F9KJYAhEhMeWeL6GkYYVaJvYC6oQEhUn5sN9fN7Uv_27fqW8S32-H0uhaEAsCwd4NgiTTUjsJWjlaFDF_XwoqfKqlXVtTscfQp3FgwGVFMP9nHfM3EphA6FhaaxmO9758WdWmz_-bWzL5XmKF7cSw2f2rwpWhBki762okp8oFUDCbbSwTuJTU1juYT0J59GeL9SYTQ5F1LGYj8I6OZSJSEgsFLSbFRoasaAAkUVhS4PDXfgEmRtnI2Om8un94hg8JT7xGJo7nSYVEy_Mg9a-ptjNT_xxJfLfTFg1_H0juTJH7aci6Sm_TCx9bjNTZA=\" rel=\"nofollow\" target=\"_blank\">contact@bridgebio.com<\/a>\u00a0\u00a0 <br \/>(650)-789-8220<\/p>\n<p>\n        <strong>BridgeBio Investor Contact:<\/strong><br \/>\n        <br \/>Chinmay Shukla, Senior Vice President, Strategic Finance<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uaYI0HTNlehSBOtEPKiYcNb2OXkFedGcCrtKxxNrLh9wjhEH_wrpCUr9PpsmN1GbhqZnp40GQMRio5-f3SheTr8yvSeFJdOit4x7RVArvxW4cSdi3wepMoGLa8ScbQ-wJ-gKtEBdsy3fddXAwIzgGuMxC9WJEwWb83Mkq36jDVnz9swfoewzGHG-TArKYX7mATArsdsDM1zkecv3hSh5-v8gN7HVB8LCv1Iyn_HOe2tCdNtM6xTGu0XrGU4m9CgIAIpUEP6u2UCanDiPZXVFId431X-sCgkrbuQQLiQAgcUJqPzpMvzRBqjLTAG-TiV_gbeN9CIOSf-inDk2yaIVRCAEbPRF50fRk4DGqfxlcQkegaB7YdI3ncHtXp-W7VuM0bnVR9twFMXuPPbg9sTzUkcnKZX09qBe87sDIupWynWse1UYmBSXJFUNyeAjtBfgZVcYAlYtqph5_HHtIw3sM3Tdwu0GgbzKtzryIxVI-g_cEDLj9XD54pB3oSUMjsjS1AT2DMa8R6aRuvz9A0CFb1pr1CCCP2RaAws87d9LGoUqtfiOOIpl2c6Pj8eWpeNC_UFY9cAFiZhs6FXoWklNBo5XnRDh0W8B8yl_WXeTq6i9tAdrEPTkFR-4rzKTyiZVbflmrUsRHf4pABy7boE3HH-bSMk9anFKaPcQyhvbRG__vRTu5R2NwdBEXpsPYf2Pl24hpnItlP_Z1KuCB9UaG4Rh_JSXPMKWfE2z6DkOjw3qyihOLDFdOgM8Et6bakNaqvzDTdM0aK3VUwW6gCemBw==\" rel=\"nofollow\" target=\"_blank\">ir@bridgebio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Mzc0NjY2YzktMzA1Mi00NmRhLWJmN2EtYjQ2NDBiMGM1MDJiLTExNjg0OTctMjAyNS0xMS0yNS1lbg==\/tiny\/BridgeBio-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences: Piper Sandler Healthcare Conference, New York, NY: Fireside Chat on Tuesday, December 2 at 10:30 am EST EvercoreISI HealthCONx Conference, Miami, FL: Fireside Chat on Wednesday, December 3 at 3:00 pm EST To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents and Presentations\u201d page within the Investors section of the BridgeBio website at https:\/\/investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BridgeBio to Participate in December Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-913486","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BridgeBio to Participate in December Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BridgeBio to Participate in December Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences: Piper Sandler Healthcare Conference, New York, NY: Fireside Chat on Tuesday, December 2 at 10:30 am EST EvercoreISI HealthCONx Conference, Miami, FL: Fireside Chat on Wednesday, December 3 at 3:00 pm EST To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents and Presentations\u201d page within the Investors section of the BridgeBio website at https:\/\/investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following &hellip; Continue reading &quot;BridgeBio to Participate in December Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-25T12:40:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BridgeBio to Participate in December Investor Conferences\",\"datePublished\":\"2025-11-25T12:40:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/\"},\"wordCount\":247,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/\",\"name\":\"BridgeBio to Participate in December Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=\",\"datePublished\":\"2025-11-25T12:40:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-december-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio to Participate in December Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BridgeBio to Participate in December Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"BridgeBio to Participate in December Investor Conferences - Market Newsdesk","og_description":"PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences: Piper Sandler Healthcare Conference, New York, NY: Fireside Chat on Tuesday, December 2 at 10:30 am EST EvercoreISI HealthCONx Conference, Miami, FL: Fireside Chat on Wednesday, December 3 at 3:00 pm EST To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents and Presentations\u201d page within the Investors section of the BridgeBio website at https:\/\/investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following &hellip; Continue reading \"BridgeBio to Participate in December Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-25T12:40:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BridgeBio to Participate in December Investor Conferences","datePublished":"2025-11-25T12:40:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/"},"wordCount":247,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/","name":"BridgeBio to Participate in December Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=","datePublished":"2025-11-25T12:40:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MTQyMiM3Mjg5OTkzIzIxNTY5MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-december-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio to Participate in December Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=913486"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/913486\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=913486"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=913486"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=913486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}